These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29896197)

  • 41. Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate.
    Fontanella GH; De Vusser K; Laroy W; Daurelio L; Nocito AL; Revelli S; Contreras R
    Vaccine; 2008 May; 26(19):2322-34. PubMed ID: 18403070
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of CD8+ T cell-mediated protective immunity against Trypanosoma cruzi.
    Miyahira Y; Kobayashi S; Takeuchi T; Kamiyama T; Nara T; Nakajima-Shimada J; Aoki T
    Int Immunol; 1999 Feb; 11(2):133-41. PubMed ID: 10069411
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi.
    Tarleton RL
    J Immunol; 1990 Jan; 144(2):717-24. PubMed ID: 2104903
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biolistic DNA vaccination against Trypanosoma infection.
    Bryan M; Guyach S; Norris KA
    Methods Mol Biol; 2013; 940():305-15. PubMed ID: 23104351
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advances and challenges towards a vaccine against Chagas disease.
    Quijano-Hernandez I; Dumonteil E
    Hum Vaccin; 2011 Nov; 7(11):1184-91. PubMed ID: 22048121
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance.
    Nickell SP; Sharma D
    Exp Parasitol; 2000 Apr; 94(4):207-16. PubMed ID: 10831388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease.
    Sánchez-Valdéz FJ; Pérez Brandán C; Ferreira A; Basombrío MÁ
    Expert Rev Vaccines; 2015 May; 14(5):681-97. PubMed ID: 25496192
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-Term Immunity to Trypanosoma cruzi in the Absence of Immunodominant trans-Sialidase-Specific CD8+ T Cells.
    Rosenberg CS; Zhang W; Bustamante JM; Tarleton RL
    Infect Immun; 2016 Sep; 84(9):2627-38. PubMed ID: 27354447
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccines and the regulatory arm of the immune system. An overview from the Trypanosoma cruzi infection model.
    Cabrera G; Marcipar I
    Vaccine; 2019 Jun; 37(28):3628-3637. PubMed ID: 31155420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Experimental Chagas disease. Innate immune response in Balb/c mice previously vaccinated with Trypanosoma rangeli. I. The macrophage shows immunological memory: Reality or fiction?
    Basso B; Marini V
    Immunobiology; 2014 Apr; 219(4):275-84. PubMed ID: 24321621
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease.
    Seid CA; Jones KM; Pollet J; Keegan B; Hudspeth E; Hammond M; Wei J; McAtee CP; Versteeg L; Gutierrez A; Liu Z; Zhan B; Respress JL; Strych U; Bottazzi ME; Hotez PJ
    Hum Vaccin Immunother; 2017 Mar; 13(3):621-633. PubMed ID: 27737611
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of IFN-γ coding plasmid supplementation in the immune response and protection elicited by Trypanosoma cruzi attenuated parasites.
    Pérez Brandán C; Mesías AC; Parodi C; Cimino RO; Pérez Brandán C; Diosque P; Basombrío MÁ
    BMC Infect Dis; 2017 Nov; 17(1):732. PubMed ID: 29178839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of a purified Trypanosoma cruzi antigen and CpG oligodeoxynucleotides for immunoprotection against a lethal challenge with trypomastigotes.
    Frank FM; Petray PB; Cazorla SI; Muñoz MC; Corral RS; Malchiodi EL
    Vaccine; 2003 Dec; 22(1):77-86. PubMed ID: 14604574
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TLR-dependent induction of IFN-beta mediates host defense against Trypanosoma cruzi.
    Koga R; Hamano S; Kuwata H; Atarashi K; Ogawa M; Hisaeda H; Yamamoto M; Akira S; Himeno K; Matsumoto M; Takeda K
    J Immunol; 2006 Nov; 177(10):7059-66. PubMed ID: 17082622
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Utility of the Trypanosoma cruzi sequence database for identification of potential vaccine candidates by in silico and in vitro screening.
    Bhatia V; Sinha M; Luxon B; Garg N
    Infect Immun; 2004 Nov; 72(11):6245-54. PubMed ID: 15501750
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice.
    Kotner J; Tarleton R
    Infect Immun; 2007 Feb; 75(2):861-9. PubMed ID: 17101658
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenoviruses encoding amastigote surface protein-2 and trans-sialidase.
    Machado AV; Cardoso JE; Claser C; Rodrigues MM; Gazzinelli RT; Bruna-Romero O
    Hum Gene Ther; 2006 Sep; 17(9):898-908. PubMed ID: 16972758
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice.
    Kumar S; Tarleton RL
    J Immunol; 2001 Apr; 166(7):4596-603. PubMed ID: 11254717
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epitopes in the Glycosylphosphatidylinositol Attachment Signal Peptide of Trypanosoma cruzi Mucin Proteins Generate Robust but Delayed and Nonprotective CD8+ T Cell Responses.
    Bunkofske ME; Perumal N; White B; Strauch EM; Tarleton R
    J Immunol; 2023 Feb; 210(4):420-430. PubMed ID: 36603035
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reaching for the Holy Grail: insights from infection/cure models on the prospects for vaccines for Trypanosoma cruzi infection.
    Bustamante J; Tarleton R
    Mem Inst Oswaldo Cruz; 2015 May; 110(3):445-51. PubMed ID: 25946159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.